| Pharmaceutical Information |
| Drug Name |
Roxithromycin |
| Drug ID |
BADD_D01975 |
| Description |
Roxithromycin is a semi-synthethic macrolide antibiotic that is structurally and pharmacologically similar to [erythromycin], [azithromycin], or [clarithromycin]. It was shown to be more effective against certain Gram-negative bacteria, particularly _Legionella pneumophila_. Roxithromycin exerts its antibacterial action by binding to the bacterial ribosome and interfering with bacterial protein synthesis. It is marketed in Australia as a treatment for respiratory tract, urinary and soft tissue infections. |
| Indications and Usage |
Used to treat respiratory tract, urinary and soft tissue infections. |
| Marketing Status |
approved; investigational; withdrawn |
| ATC Code |
J01FA06 |
| DrugBank ID |
DB00778
|
| KEGG ID |
D01710
|
| MeSH ID |
D015575
|
| PubChem ID |
444037
|
| TTD Drug ID |
D0Y4FL
|
| NDC Product Code |
Not Available |
| UNII |
21KOF230FA
|
| Synonyms |
Roxithromycin | Rulide | Infectoroxit | Rulid | Macrosil | MTW-Roxithromycin | Rotesan | Rotramin | Roxi 1A Pharma | Roxi-paed 1A Pharma | Roxi Basics | Roxi TAD | roxi von ct | Roxi-Puren | Roxi-Q | Roxi-saar | Roxi-Wolff | Roxibeta | roxidura | Roxigamma | Roxigrün | Roxihexal | Roxithro-Lich | RU 28965 | RU-28965 | RU28965 | RU 965 | RU-965 | RU965 | Biaxsig | Claramid |
|
| Chemical Information |
| Molecular Formula |
C41H76N2O15 |
| CAS Registry Number |
80214-83-1 |
| SMILES |
CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(
O3)C)N(C)C)O)(C)O)C)C)O)(C)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
